303 Days to Go
Today in Brexit: With Italy dominating the headlines, a prominent anti-Brexit voice has a warning for the EU.
Less than two years after the Brexit vote, a new crisis is brewing in Europe.
Political turmoil in Italy rocked global markets yesterday, sparked by the prospect of anti-Europe, nationalist parties turning an election into a de facto referendum on Italy’s membership of the euro. Bond yields soared and the single currency fell. The British pound didn’t escape the selloff, falling to a six-month low against the dollar as investors sought the safest assets.
The turbulence, greeted with glee by some pro-Leave campaigners in Britain, recalls the chaos of the region’s debt crisis earlier this decade. It also serves as a timely reminder that the U.K.’s rocky process toward the exit isn’t quelling anti-EU movements across the continent, and that Europe’s problems do not stop at Brexit.
Top 5 Safest Stocks To Invest In Right Now: Northwest Biotherapeutics, Inc.(NWBO)
- [By ]
The last time we left Northwest Biotherapeutics (OTC:NWBO), I stated in a fairly cautious article that there are persistent risks associated with an investment in this company. Back in November, I did not feel that the benefits outweighed the risks for this small cap equity.
- [By ]
Northwest Biotherapeutics (OTC:NWBO) presented underwhelming preliminary data from a late-stage study of DCVax-L in brain cancer.
Community Health Systems (NYSE:CYH) amended to extend the “Early Tender Deadline” and the “Expiration Date” for each Exchange Offer announced earlier.
Top 5 Safest Stocks To Invest In Right Now: Fitbit, Inc.(FIT)
- [By Brian Withers]
Just when Fitbit (NYSE:FIT) investors were hoping for a glimmer of good news in the company’s fourth quarter earnings report, it seems this wearable device maker’s turnaround has stalled.
- [By Brian Withers]
Fitbit (NYSE:FIT) has had a tough go of it lately. The fitness tracker wearables manufacturer posted negative revenue growth in Q1-2018 of 17%, widening losses, and declared its transition year has been extended into a multi-year transformational effort. It would not be a surprise if even die-hard investors were getting impatient with the stock down over 80% since its IPO in June 2015.
- [By Demitrios Kalogeropoulos]
The consumer shift away from cheaper activity trackers is having a much smaller impact on Garmin’s business than it is for peer Fitbit (NYSE:FIT). Investors can credit its wider portfolio of advanced wearable products for that success.
- [By Douglas A. McIntyre]
Fitbit Inc. (NYSE: FIT) had a bit of good news recently as sales of its Versa product rose. However, the news, which helped the share price, was not enough to counterbalance a horrible financial performance and shares that have plummeted 55% in the past two years. Chief Financial Officer William Zerella has jumped ship for another job. Shareholders would be fortunate if Chief Executive Officer James Park followed him.
- [By Timothy Green]
Fitness-tracker and smartwatch company Fitbit (NYSE:FIT) reported its second-quarter results after the market closed on Aug. 1. Revenue continued to slump as fitness-tracker sales tumbled, but smartwatch sales are booming thanks to the mass-market Versa.
Top 5 Safest Stocks To Invest In Right Now: CASI Pharmaceuticals, Inc.(CASI)
- [By Logan Wallace]
BidaskClub downgraded shares of CASI Pharmaceuticals (NASDAQ:CASI) from a strong-buy rating to a buy rating in a report released on Saturday morning.
- [By Maxx Chatsko]
Shares of CASI Pharmaceuticals (NASDAQ:CASI) jumped nearly 32% today after the small-cap pharma announced a new contract drug-manufacturing pact in China. The company now will rely on Yiling Wanzhou International Pharmaceuticals for manufacturing two drugs: entecavir and cilostazol.
Top 5 Safest Stocks To Invest In Right Now: MakeMyTrip Limited(MMYT)
- [By Motley Fool Transcribing]
MakeMyTrip (NASDAQ:MMYT) Q1 2019 Earnings Conference CallAug. 14, 2018 7:30 a.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Logan Wallace]
MakeMyTrip Limited (NASDAQ:MMYT) hit a new 52-week high and low during trading on Tuesday . The stock traded as low as $41.70 and last traded at $40.35, with a volume of 24850 shares trading hands. The stock had previously closed at $39.10.
- [By Lee Jackson]
MakeMyTrip Limited (NASDAQ: MMYT) was downgraded to neutral from buy at Goldman Sachs. The stock’s price over a 52-week range has been $22.40 to $41.30. The consensus price target is set at $37.59. With the shares closing at $41.05, this could be a valuation call.
Top 5 Safest Stocks To Invest In Right Now: eHealth Inc.(EHTH)
- [By Lisa Levin]
Shares of eHealth, Inc. (NASDAQ: EHTH) got a boost, shooting up 16 percent to $18.64 as the company posted upbeat Q1 results.
Enova International, Inc. (NYSE: ENVA) shares were also up, gaining 25 percent to $28.35 following Q1 results.
- [By Logan Wallace]
Los Angeles Capital Management & Equity Research Inc. boosted its stake in eHealth, Inc. (NASDAQ:EHTH) by 61.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,655 shares of the financial services provider’s stock after acquiring an additional 8,630 shares during the period. Los Angeles Capital Management & Equity Research Inc. owned about 0.12% of eHealth worth $501,000 as of its most recent SEC filing.
- [By Lisa Levin] Gainers
Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
- [By Lisa Levin]
Shares of eHealth, Inc. (NASDAQ: EHTH) got a boost, shooting up 19 percent to $19.04 as the company posted upbeat Q1 results.
SVB Financial Group (NASDAQ: SIVB) shares were also up, gaining 17 percent to $301.12 following strong quarterly results.
- [By Shane Hupp]
Get a free copy of the Zacks research report on eHealth (EHTH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
ValuEngine lowered shares of eHealth (NASDAQ:EHTH) from a buy rating to a hold rating in a research report report published on Tuesday.
EHTH has been the topic of several other reports. Cantor Fitzgerald boosted their price target on shares of eHealth to $22.00 and gave the stock an overweight rating in a report on Friday, May 18th. Chardan Capital initiated coverage on shares of eHealth in a report on Thursday, August 16th. They set a buy rating and a $40.00 price target on the stock. BidaskClub upgraded shares of eHealth from a buy rating to a strong-buy rating in a report on Thursday, August 16th. Finally, Zacks Investment Research cut shares of eHealth from a hold rating to a sell rating in a report on Wednesday, August 1st. Four equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus target price of $26.86.